Title:
トリアゾロピリジンＪＡＫ阻害剤化合物と方法
Document Type and Number:
Japanese Patent JP5595389
Kind Code:
B2
Abstract:
A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined herein, are useful as JAK kinase inhibitors. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of JAK kinase activity in a patient are disclosed.
More Like This:
Inventors:
チュ and bottle * Jan
Siu and Michael
Magnuson, Stephen, and Earle.
Pastor and Richard
Hying and ヘ
イソン and Shao
ジフ and a chain
Singh and Soe
ジュンピン and ciao
Lew and Wendy
Siu and Michael
Magnuson, Stephen, and Earle.
Pastor and Richard
Hying and ヘ
イソン and Shao
ジフ and a chain
Singh and Soe
ジュンピン and ciao
Lew and Wendy
Application Number:
JP2011514866A
Publication Date:
September 24, 2014
Filing Date:
June 19, 2009
Export Citation:
Assignee:
Genentech and in condominium lei テッド
International Classes:
A61K31/437; C07D471/04; A61K31/444; A61K31/4545; A61K31/496; A61K31/5377; A61K31/541; A61P1/16; A61P3/10; A61P5/00; A61P7/00; A61P7/02; A61P9/00; A61P9/04; A61P9/10; A61P11/16; A61P13/12; A61P17/00; A61P17/06; A61P19/02; A61P19/08; A61P21/02; A61P25/00; A61P25/14; A61P25/16; A61P25/28; A61P29/00; A61P31/12; A61P35/00; A61P35/02; A61P37/02; A61P37/06; A61P37/08; A61P43/00
Attorney, Agent or Firm:
Yoshitaka Sonoda
Yoshinori Kobayashi
Yoshinori Kobayashi
Previous Patent: リン酸カルシウムを含有する生体材料
Next Patent: METHOD OF FORMING MOLDED ARTICLE HAVING PRINTED CIRCUIT PORTION
Next Patent: METHOD OF FORMING MOLDED ARTICLE HAVING PRINTED CIRCUIT PORTION